Nature Medicine Features KineMed, Inc.'s Fibrosis Research, Which Aims to Advance Therapeutics for the Underlying Cause of 45% of All Deaths

Published: Jan 20, 2011

(BUSINESS WIRE)--KineMed Inc.’s ( fibrosis research program, which aims to advance the discovery and development of drugs to treat this major disease, is featured in the January edition of Nature Medicine.

Back to news